Compounding inequity: a qualitative study of gout management in an urban marae clinic in Auckland.

INTRODUCTION Gout remains a health equity issue; Māori and Pacific peoples are disproportionately afflicted, with increased burden and loss of quality of life, yet are less likely to receive appropriate management, which mainly occurs in primary care. AIM This study aims to understand the perspectives of the mainly Māori and Pacific clinicians and staff at an urban marae practice about barriers and challenges to delivering effective care to a Māori and Pacific community with high burden of gout. METHODS Semi-structured interviews were conducted with 10 staff members delivering health care to a mostly Indigenous community. Interviews sought to ascertain staff views of enablers and barriers to optimal gout management and analyse them thematically. RESULTS Three themes were identified: community disadvantage; demands unique to Indigenous providers; and challenges and opportunities for optimising gout management. High prevalence and heavy impact of gout on wellbeing in the community was intertwined with socioeconomic disadvantage, precariousness of employment and entrenched inaccurate (yet pliable) patient views on gout, to the detriment of focused, effective care. Structural and funding demands on providers inhibited staff focus on the clear community need. Providers saw the culturally safe and competent approach necessary for improvement as requiring community empowerment with appropriate clinical tools and adequate resourcing. DISCUSSION Despite provider intent to deliver culturally appropriate and safe care and equitable health outcomes for patients suffering from gout, general practice initiatives without aligned resourcing or incentives are inhibited when inequity is pervasive. Simply asking Māori providers to do more for the same amount of resource may not be effective.

[1]  B. Arroll,et al.  The long shadow of inequity for Māori with gout , 2020, MAI Journal: A New Zealand Journal of Indigenous Scholarship.

[2]  J. Atkinson,et al.  A comparison of the NZDep and New Zealand IMD indexes of socioeconomic deprivation , 2020, Kōtuitui: New Zealand Journal of Social Sciences Online.

[3]  P. Crampton,et al.  The primary healthcare claims to the Waitangi Tribunal. , 2019, The New Zealand medical journal.

[4]  S. Ameratunga,et al.  Gaming New Zealand’s Emergency Department Target: How and Why Did It Vary Over Time and Between Organisations? , 2019, International journal of health policy and management.

[5]  B. Arroll,et al.  Making the right thing the easy thing to do: strategies to improve outcomes in gout. , 2019, The Lancet. Rheumatology.

[6]  L. Joosten,et al.  Gout , 2019, Nature Reviews Disease Primers.

[7]  N. Rashid,et al.  Adherence and Outcomes with Urate-Lowering Therapy: A Site-Randomized Trial. , 2019, The American journal of medicine.

[8]  N. Dalbeth,et al.  Gout in Aotearoa New Zealand: the equity crisis continues in plain sight. , 2018, The New Zealand medical journal.

[9]  L. Duley,et al.  Efficacy and cost-effectiveness of nurse-led care involving education and engagement of patients and a treat-to-target urate-lowering strategy versus usual care for gout: a randomised controlled trial , 2018, The Lancet.

[10]  T. Tenbensel,et al.  Measuring and managing health system performance: An update from New Zealand. , 2017, Health policy.

[11]  T. McCreanor,et al.  Institutional racism in public health contracting: Findings of a nationwide survey from New Zealand. , 2017, Social science & medicine.

[12]  E. Curtis Indigenous Positioning in Health Research: The importance of Kaupapa Māori theory-informed practice , 2016 .

[13]  B. Arroll,et al.  A qualitative study to explore health professionals' experience of treating gout: understanding perceived barriers to effective gout management. , 2016, Journal of primary health care.

[14]  N. Dalbeth Management of gout in primary care: challenges and potential solutions. , 2013, Rheumatology.

[15]  K. Petrie,et al.  The experience and impact of gout in Māori and Pacific people: a prospective observational study , 2013, Clinical Rheumatology.

[16]  K. Wilson,et al.  Pay-for-Performance in Health Care: What Can We Learn From International Experience? , 2013, Quality management in health care.

[17]  J. Grimshaw,et al.  Overview of systematic reviews of the effectiveness of reminders in improving healthcare professional behavior , 2012, Systematic Reviews.

[18]  M. Doherty,et al.  Patient and provider barriers to effective management of gout in general practice: a qualitative study , 2012, Annals of the rheumatic diseases.

[19]  V. Entwistle,et al.  Pay-for-virtue: an option to improve pay-for-performance? , 2011, Journal of evaluation in clinical practice.

[20]  P. Gow,et al.  Societal and Cultural Attitudes to Gout: An Important Consideration in the Successful Management of Gout among Maori in Aotearoa New Zealand , 2011 .

[21]  D. Khanna,et al.  Long-term therapy for chronic gout results in clinically important improvements in the health-related quality of life: short form-36 is responsive to change in chronic gout. , 2011, Rheumatology.

[22]  Sarah Velten,et al.  Patients and providers view gout differently: a qualitative study , 2010, Chronic illness.

[23]  Johnny Saldaña,et al.  The Coding Manual for Qualitative Researchers , 2009 .

[24]  Sallie-Anne Pearson,et al.  Interventions designed to improve the quality and efficiency of medication use in managed care: A critical review of the literature – 2001–2007 , 2008, BMC health services research.

[25]  C. Hood,et al.  What's measured is what matters: targets and gaming in the English public health care system , 2006 .

[26]  David Parkin,et al.  Effect of computerised evidence based guidelines on management of asthma and angina in adults in primary care: cluster randomised controlled trial , 2002, BMJ : British Medical Journal.

[27]  Linda Smith,et al.  Decolonizing Methodologies: Research and Indigenous Peoples , 2000 .

[28]  S. Larkins,et al.  Management of gout in general practice—a systematic review , 2014, Clinical Rheumatology.